Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page
- Check7 days agoChange DetectedNo changes were detected for the page based on the provided data. The content remains unchanged.SummaryDifference0.2%

- Check14 days agoChange DetectedNo additions or deletions were detected in the page content, so the page remains unchanged.SummaryDifference0.2%

- Check21 days agoChange DetectedA minor update to the ClinicalTrials.gov page release/version label (v3.5.2 → v3.5.3) with no change to the displayed study details.SummaryDifference0.3%

- Check29 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.2%

- Check36 days agoChange DetectedUpdated the study record with results-related information and revised dates. Included details such as the results posting date and study completion.SummaryDifference0.2%

- Check43 days agoChange DetectedAlström syndrome was added to the list of study conditions, explicitly including AS in the study details.SummaryDifference0.2%

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.